rs139449383
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001368397.1(FRMPD4):c.388G>A(p.Ala130Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00087 in 1,181,909 control chromosomes in the GnomAD database, including 1 homozygotes. There are 339 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00099 ( 0 hom., 32 hem., cov: 22)
Exomes 𝑓: 0.00086 ( 1 hom. 307 hem. )
Consequence
FRMPD4
NM_001368397.1 missense
NM_001368397.1 missense
Scores
2
14
Clinical Significance
Conservation
PhyloP100: 3.76
Genes affected
FRMPD4 (HGNC:29007): (FERM and PDZ domain containing 4) This gene encodes a multi-domain (WW, PDZ, FERM) containing protein. Through its interaction with other proteins (such as PSD-95), it functions as a positive regulator of dendritic spine morphogenesis and density, and is required for the maintenance of excitatory synaptic transmission. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.006225556).
BP6
Variant X-12614847-G-A is Benign according to our data. Variant chrX-12614847-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 211053.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-12614847-G-A is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 32 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRMPD4 | NM_001368397.1 | c.388G>A | p.Ala130Thr | missense_variant | 4/17 | ENST00000675598.1 | NP_001355326.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRMPD4 | ENST00000675598.1 | c.388G>A | p.Ala130Thr | missense_variant | 4/17 | NM_001368397.1 | ENSP00000502607.1 |
Frequencies
GnomAD3 genomes AF: 0.000990 AC: 110AN: 111056Hom.: 0 Cov.: 22 AF XY: 0.000963 AC XY: 32AN XY: 33242
GnomAD3 genomes
AF:
AC:
110
AN:
111056
Hom.:
Cov.:
22
AF XY:
AC XY:
32
AN XY:
33242
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000904 AC: 164AN: 181428Hom.: 1 AF XY: 0.000879 AC XY: 58AN XY: 65962
GnomAD3 exomes
AF:
AC:
164
AN:
181428
Hom.:
AF XY:
AC XY:
58
AN XY:
65962
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000857 AC: 918AN: 1070799Hom.: 1 Cov.: 24 AF XY: 0.000906 AC XY: 307AN XY: 338745
GnomAD4 exome
AF:
AC:
918
AN:
1070799
Hom.:
Cov.:
24
AF XY:
AC XY:
307
AN XY:
338745
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000990 AC: 110AN: 111110Hom.: 0 Cov.: 22 AF XY: 0.000961 AC XY: 32AN XY: 33306
GnomAD4 genome
AF:
AC:
110
AN:
111110
Hom.:
Cov.:
22
AF XY:
AC XY:
32
AN XY:
33306
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
6
ExAC
AF:
AC:
106
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 15, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Benign
T;.
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at